Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Pelossof

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Cancer Research : MCR|April 8, 2022
KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal CancerSeo-Hyun Choi, Jin K Kim, Chin-Tung Chen, et al.
Nature Biotechnology|March 7, 2017
Prediction of potent shRNAs with a sequential classification algorithmRaphael Pelossof, Lauren Fairchild, Chun-Hao Huang, et al.
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Nature Medicine|October 9, 2019
A rectal cancer organoid platform to study individual responses to chemoradiationKaruna Ganesh, Chao Wu, Kevin P O'Rourke, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Cancer Research : MCR|April 8, 2022
KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal CancerSeo-Hyun Choi, Jin K Kim, Chin-Tung Chen, et al.
Nature Biotechnology|March 7, 2017
Prediction of potent shRNAs with a sequential classification algorithmRaphael Pelossof, Lauren Fairchild, Chun-Hao Huang, et al.
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Nature Medicine|October 9, 2019
A rectal cancer organoid platform to study individual responses to chemoradiationKaruna Ganesh, Chao Wu, Kevin P O'Rourke, et al.
Pageof 2